Timothy D. Ocain
Plus aucun poste en cours
Profil
Timothy D.
Ocain worked as Vice President-Inflammation Discovery at Millennium Pharmaceuticals, Inc. from 1998 to 2006.
He then worked as Senior VP-New Product Strategy & Development at Enanta Pharmaceuticals, Inc. before becoming Senior Vice President-Research & Development at Seaside Therapeutics LLC from 2006 to 2009.
Ocain holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of Wisconsin-Eau Claire.
Anciens postes connus de Timothy D. Ocain
| Sociétés | Poste | Fin |
|---|---|---|
Seaside Therapeutics LLC
 Seaside Therapeutics LLC Medical DistributorsDistribution Services Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/01/2009 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2006 |
| ENANTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Timothy D. Ocain
| University of Wisconsin-Eau Claire | Undergraduate Degree |
| University of Wisconsin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Seaside Therapeutics LLC
Seaside Therapeutics LLC Medical DistributorsDistribution Services Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA. | Distribution Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
